ACH-702, a novel isothiazoloquinolone, was assessed for antibacterial activity against a panel of gram-positive and gram-negative clinical isolates and found to possess broad-spectrum activity, especially against antibiotic-resistant gram-positive strains including methicillin-resistant Staphylococcus aureus (MRSA).
Recent Posts
- News: Swab Predicts MRSA-Related GI Infection
- How one strain of MRSA becomes resistant to last-line antibiotic | Science Codex
- Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity
- Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic
- Antiseptic resistance genes qacA/B and MRSA in the era of hand hygiene
- Altered vancomycin pharmacokinetics in obese patients
- MLVF with new primer sets for Methicillin-Resistant Staphylococcus aureus.
- Staphylococcus aureus Protein A Polymorphic Region Regulates Inflammation: Impact on Acute and Chronic Infection
- Correlation between glove use practices and compliance with hand hygiene in a multicenter study with elderly patients
- How IBM Plans To Kill the Staph Superbug - Forbes
Search here. Single words (leave out MRSA) are best
